VanEck Associates’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8M | Sell |
119,987
-673
| -0.6% | -$71.7K | 0.01% | 419 |
|
|
2025
Q1 | $11M | Buy |
120,660
+2,242
| +2% | +$204K | 0.01% | 454 |
|
|
2024
Q4 | $13.5M | Buy |
118,418
+23,733
| +25% | +$2.7M | 0.02% | 392 |
|
|
2024
Q3 | $10.5M | Sell |
94,685
-25,216
| -21% | -$2.8M | 0.01% | 437 |
|
|
2024
Q2 | $9.64M | Buy |
119,901
+2,192
| +2% | +$176K | 0.01% | 426 |
|
|
2024
Q1 | $10.9M | Buy |
117,709
+9,013
| +8% | +$831K | 0.02% | 382 |
|
|
2023
Q4 | $11.5M | Sell |
108,696
-17,318
| -14% | -$1.83M | 0.02% | 341 |
|
|
2023
Q3 | $13.7M | Sell |
126,014
-5,993
| -5% | -$651K | 0.03% | 301 |
|
|
2023
Q2 | $14.2M | Sell |
132,007
-4,639
| -3% | -$501K | 0.03% | 296 |
|
|
2023
Q1 | $17M | Sell |
136,646
-13,030
| -9% | -$1.62M | 0.04% | 261 |
|
|
2022
Q4 | $22.5M | Buy |
149,676
+25,715
| +21% | +$3.86M | 0.06% | 230 |
|
|
2022
Q3 | $16.7M | Sell |
123,961
-11,137
| -8% | -$1.5M | 0.05% | 246 |
|
|
2022
Q2 | $20.1M | Sell |
135,098
-8,029
| -6% | -$1.2M | 0.05% | 243 |
|
|
2022
Q1 | $24.4M | Buy |
143,127
+51,437
| +56% | +$8.77M | 0.05% | 227 |
|
|
2021
Q4 | $23.6M | Buy |
91,690
+3,820
| +4% | +$985K | 0.05% | 237 |
|
|
2021
Q3 | $24M | Sell |
87,870
-16,533
| -16% | -$4.51M | 0.06% | 231 |
|
|
2021
Q2 | $23.4M | Sell |
104,403
-27,288
| -21% | -$6.11M | 0.06% | 236 |
|
|
2021
Q1 | $14.4M | Sell |
131,691
-24,763
| -16% | -$2.7M | 0.04% | 280 |
|
|
2020
Q4 | $12.8M | Buy |
156,454
+44,986
| +40% | +$3.67M | 0.04% | 267 |
|
|
2020
Q3 | $7.72M | Buy |
+111,468
| New | +$7.72M | 0.02% | 298 |
|